GenEng News  Sep 29  Comment 
Intrexon is joining forces with Ziopharm Oncology in a collaboration that will concentrate on the treatment and prevention of graft-versus-host disease (GvHD). GvHD is a major complication of allogeneic hematopoietic stem-cell transplantation...
Benzinga  Sep 28  Comment 
Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today it has formed a new Exclusive Channel Collaboration (ECC) with ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), a biopharmaceutical company focused on new cancer...
Motley Fool  Sep 7  Comment 
A shift in investor sentiment and a mixed second-quarter earnings report are all it took to send Ziopharm down by 35% in August. Does this stock stand a chance to recover?
TheStreet.com  Jun 22  Comment 
NEW YORK (TheStreet) -- Shares of ZIOPHARM Oncology Inc  were up 0.41% to $12.19 in mid-morning trading Monday, despite getting a rating cut by analysts at BMO Capital earlier this morning. The firm downgraded shares of the biotechnology...
Benzinga  Jun 5  Comment 
Intrexon Corporation ("Intrexon") (NYSE: XON), a leader in synthetic biology, today announced that it has determined the final distribution ratio relating to its previously announced distribution of all of its 17,830,305 shares of ZIOPHARM...
Benzinga  Jun 2  Comment 
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that Caesar J. Belbel, Executive Vice President, Chief Legal Officer and Secretary, has...
Motley Fool  Apr 27  Comment 
Ziopharm Oncology shares are heading lower as investors book profits after a big move this year.



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki